What’s on the horizon in 2021 and beyond for treatment options for mental illness and substance use disorder? Join Stephanie Kornechuk, PharmD, Genoa Healthcare’s Senior Vice President of Procurement, for an up-to-the-minute briefing on the new and upcoming treatment options for major depressive disorder, schizophrenia, bipolar disorder, and other forms of illness. She will provide an overview of newly-approved medications and medications pending approval in the pipeline. Dr. Kornechuk will also discuss pending policy changes that may improve accessibility to cutting edge medications for opioid use disorder.
Originally presented on 6/29/21